[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352301-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352301-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","clinical-tolerability-and-safety-of-ketogenic-diet-in-patients-with-gynecological-malignancies-undergoing-radiotherapy-preliminary-results-of-a-prospective-randomized-open-label-trial-komparc","Clinical Tolerability and Safety of Ketogenic Diet in Patients with Gynecological Malignancies Undergoing Radiotherapy - Preliminary Results of a Prospective, Randomized, Open-Label Trial (KOMPARC)","","Radiotherapy is a common treatment for gynecological malignancies, frequently causing side effects that can worsen patients' nutritional status. The ketogenic diet has been proposed as a complementary approach to improve tolerability and support body composition, but its safety and feasibility in oncology require stronger evidence. The KOMPARC study randomized cervical and endometrial cancer patients undergoing radiotherapy to ketogenic or standard Mediterranean diets, evaluating adherence, safety, tolerability, and body-composition changes. Preliminary results from 33 patients showed comparable adherence and no significant differences in gastrointestinal toxicity, while both groups reduced weight without differential body-cell-mass loss and noted QoL symptom profile differences.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinical-tolerability-and-safety-of-ketogenic-diet-in-patients-with-gynecological-malignancies-undergoing-radiotherapy-preliminary-results-of-a-prospective-randomized-open-label-trial-komparc/352301/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinical-tolerability-and-safety-of-ketogenic-diet-in-patients-with-gynecological-malignancies-undergoing-radiotherapy-preliminary-results-of-a-prospective-randomized-open-label-trial-komparc/352301.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the KOMPARC trial evaluating?","Question",{"text":63,"@type":64},"The KOMPARC study evaluates adherence, safety, and clinical tolerability of a ketogenic diet versus a standard Mediterranean diet in cervical and endometrial cancer patients undergoing radiotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did ketogenic diet affect gastrointestinal side effects?",{"text":68,"@type":64},"No significant differences were reported between the ketogenic and standard diet groups for gastrointestinal toxicities, including diarrhea and nausea.",{"name":70,"@type":61,"acceptedAnswer":71},"Were there differences in weight loss or body composition?",{"text":72,"@type":64},"Both groups experienced significant weight reduction during therapy, without differential loss of body cell mass or other body composition parameters.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352301,1790198280,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Article  \nClinical Tolerability and Safety of Ketogenic Diet in Patients with Gynecological Malignancies Undergoing Radiotherapy:  \nPreliminary Results of a Prospective, Randomized, Open-Label Trial (KOMPARC)  \nMarco Cintoni 1,2, *,†, Rosa Autorino 3,†, Raffaella Michela Rinaldi 3, *, Elena Leonardi 1, Marta Palombaro 1, Giuditta Chiloiro 3, Viola De Luca 3, Pauline Celine Raoul 1, Emanuele Rinninella 1,2,4,  \nEsmeralda Capristo 2,4,5, Antonio Gasbarrini 2,4,6, Maria Antonietta Gambacorta 3,7  \nand Maria Cristina Mele 1,2,4  \nAcademic Editors: Marta Correia and Yoichi Matsuo  \nReceived: 1 December 2025  \nRevised: 2 January 2026  \nAccepted: 15 January 2026  \nPublished: 19 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 UOC di Nutrizione Clinica, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy; elena.leonardi03@icatt.it (E.L.); [marta.palombaro@guest.policlinicogemelli.it](marta.palombaro@guest.policlinicogemelli.it) (M.P.); [paulineceline.raoul@policlinicogemelli.it](paulineceline.raoul@policlinicogemelli.it) (P.C.R.); [emanuele.rinninella@unicatt.it](emanuele.rinninella@unicatt.it) (E.R.); [mariacristina.mele@unicatt.it](mariacristina.mele@unicatt.it) (M.C.M.)  \n2 Centro di Ricerca e Formazione in Nutrizione Umana, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; [esmeralda.capristo@unicatt.it](esmeralda.capristo@unicatt.it) (E.C.); [antonio.gasbarrini@unicatt.it](antonio.gasbarrini@unicatt.it) (A.G.)  \n3 UOC Radioterapia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy; [rosa.autorino@policlinicogemelli.it](rosa.autorino@policlinicogemelli.it) (R.A.); giuditta.chiloiro@policlinicogemelli.it (G.C.); [viola.deluca@policlinicogemelli.it](viola.deluca@policlinicogemelli.it) (V.D.L.); [mariaantonietta.gambacorta@policlinicogemelli.it](mariaantonietta.gambacorta@policlinicogemelli.it) (M.A.G.)  \n4 Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy  \n5 UOS Medicina della Grande Obesità, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy  \n6 UOC Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy  \n7 Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore,  \n00168 Rome, Italy  \n* [Correspondence: marco.cintoni@unicatt.it](Correspondence: marco.cintoni@unicatt.it) (M.C.); [raffaellamichela.rinaldi@guest.policlinicogemelli.it](raffaellamichela.rinaldi@guest.policlinicogemelli.it) (R.M.R.)† These authors contributed equally to this work.  \nAbstract  \nBackground: Radiotherapy is a common treatment for gynecological malignancies, often accompanied by significant side effects that impact patient nutritional status. The ketogenic diet has been proposed as a complementary nutritional strategy to enhance treatment efficacy, manage side effects, and preserve body composition. However, its safety and feasibility in the oncological setting remain under-investigated. Methods: The KOMPARC study is a prospective, randomized controlled trial evaluating the adherence, safety, and clinical tolerability of a ketogenic diet versus a standard Mediterranean diet in patients with cervical and endometrial cancer undergoing radiotherapy. Before the start of the treatment, patients were randomized to either the ketogenic diet or the standard diet groups. Anthropometric measures, Hand Grip Test, and body composition parameters from bioimpedance analysis were taken b","cbCairkxzXIRVYTj","https://ap.wps.com/l/cbCairkxzXIRVYTj","pdf",738986,14,"English","# Abstract\n# 1. Introduction\n## Background and standard of care\n## Rationale for ketogenic diet in radiotherapy","[{\"question\":\"What is the KOMPARC trial evaluating?\",\"answer\":\"The KOMPARC study evaluates adherence, safety, and clinical tolerability of a ketogenic diet versus a standard Mediterranean diet in cervical and endometrial cancer patients undergoing radiotherapy.\"},{\"question\":\"How did ketogenic diet affect gastrointestinal side effects?\",\"answer\":\"No significant differences were reported between the ketogenic and standard diet groups for gastrointestinal toxicities, including diarrhea and nausea.\"},{\"question\":\"Were there differences in weight loss or body composition?\",\"answer\":\"Both groups experienced significant weight reduction during therapy, without differential loss of body cell mass or other body composition parameters.\"}]","Clinical Tolerability and Safety of Ketogenic Diet in Patients with Gynecological Malignancies Undergoing Radiotherapy - Preliminary Results of a Prospective, Randomized, Open-Label Trial (KOMPARC) | PDF",1790098811,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12d9c9e905580043950af13cb55009a4.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/971350ee7eeab0b7858ef506115c066a.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d558f10c080b4c9f6cf8c1708696f0a7.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87a7c1511bb58b05ff9b62f53243eb33.webp",980,1385]